Daily PubMed evidence board
Effectiveness of BRIX3000 for chemo-mechanical caries removal: a systematic review and meta-analysis of time and pain outcomes.
This systematic review and meta-analysis pooled randomized trials comparing BRIX3000 (a chemical gel used to remove dental caries without drilling) to con…
Signal score64Research triage score
CertaintyModerateVerify in full text
PMID42249146Source identifier
Research triage, not medical advice
Do not use this summary, score, or benefit-cost estimate to diagnose, treat, prescribe, or change care without reviewing the full study and consulting qualified professionals.
Verify before acting
Check full-text methods, eligibility, outcomes, risk of bias, harms, conflicts, funding, replication, and applicability.
Plain-English signal
This systematic review and meta-analysis pooled randomized trials comparing BRIX3000 (a chemical gel used to remove dental caries without drilling) to conventional rotary instruments or other atraumatic techniques. Across nine trials (eight in children, one in adults), BRIX3000 took longer on average to remove caries but was associated with lower self-reported pain scores among children. Complete caries removal rates were similar between BRIX3000 and comparators. The authors note substantial variation across studies and limited adult data, and they call for larger, longer trials. Overall, BRIX3000 may be a useful option for children and anxious patients if slightly longer procedure time is acceptable.
Why it matters
- Addresses effectiveness and safety of BRIX3000, a chemo-mechanical caries removal agent relevant to dentists treating dentinal carious lesions in primary and permanent teeth.
- Reports on procedural time and patient pain - outcomes important for paediatric care and for patients with dental anxiety.
- Finds pain reduction in paediatric patients which could influence tool selection for anxiety-prone children, despite longer procedure time.
Primary outcomes
- Procedure time required for caries removal
- Pain experienced during the procedure (Wong-Baker FACES scale)
- Complete caries removal
Effect summary
Abstract-reported pooled results: BRIX3000 was associated with longer mean caries removal time (MD 4.58 min, 95% CI 2.45 to 6.70) and lower paediatric pain scores (Wong-Baker FACES MD -2.50, 95% CI -4.37 to -0.62). No significant difference in complete caries removal in paediatric or adult subgroups. All pooled estimates had substantial heterogeneity; adult evidence limited.
Benefit-cost lens
| Quick take | This meta-analysis suggests BRIX3000 reduces paediatric procedural pain but increases removal time; determining net benefit for a service requires local cost, workflow, and population estimates. |
|---|---|
| BCR anchor | 2 |
| Time horizon | 3 |
| Discount rate | 0.03 |
| Assumptions | Assessment based on PubMed metadata and abstract only; full-text review may change effect estimates, heterogeneity interpretation, and safety signals. |
Benefit-cost fields are assumptions-based unless explicitly source-derived. Treat them as prompts for deeper economic review.
Risk of bias
| Tool | RoB 2 (as reported in abstract) with rapid-abstract-screen confirmation |
|---|---|
| Verdict | Some concerns |
| Notes | Abstract states most included studies judged low overall risk on RoB 2, but high between-study heterogeneity, short follow-up, and limited adult data warrant cautious interpretation. This is an abstract-level assessment; full-text review could change risk-of-bias judgment. |
Harms, equity, conflicts & implementation
| Implementation | Full-text review, confirmation of comparators and protocols, local cost and consumable pricing for BRIX3000, training needs, workflow impact assessment (longer procedure time), and stakeholder (clinician/parent) acceptability evaluation. |
|---|---|
| Equity impact | Unclear from abstract; potential equity considerations if BRIX3000 is more accessible in some settings or if longer procedure times disproportionately limit access for high-demand clinics. Full-text needed to assess subgroup effects by socioeconomic status or access. |
| Harms | No specific harms reported in the abstract. Harms and adverse events require verification in full text and individual trial reports. |
| Replication | Unknown from abstract-level triage; replication across larger, longer trials recommended. |
Source links — verify original
Use PubMed and full-text links to confirm methods, population, outcomes, harms, conflicts, and applicability.